FDA

Breakthrough Device Designation

  • Granted March 2026

How Coredio Works

Patient-specific AI models and device-agnostic sensor-fusion, enables early HF escalation alerts and on-demand actionable intracardiac insights

The Complete Process

Five clear steps from onboarding to clinical action

Patient Onboarding

Patient enrollment with baseline health history, device assignment, and initial clinical assessment.

  • Patient consent and enrollment
  • Wearable device pairing
  • Initial health assessment

One-Time Calibration

A 3-minute clinical session using PPG, ECG, ultrasound, and blood pressure to create a personalized digital twin. The care team collects routine baseline measurements using existing non-invasive clinical tools to personalize the patient-specific model.

  • Multi-signal capture
  • Ultrasound-informed measurements
  • Patient-specific baseline creation

Device-Based Data Capture

Patients use their smartwatch and arm cuff at home or clinic for ongoing cardiovascular signal collection.

  • Wearable signal monitoring
  • Blood pressure measurements
  • Flexible home or clinic use

AI Analysis and Estimation

Advanced algorithms combine physics-based modeling with AI to estimate hemodynamic parameters from collected signals.

  • Signal processing
  • Physics-informed AI modeling
  • Hemodynamic parameter estimation

Clinician Review and Action

Care teams review trends, respond to alerts, and make informed decisions based on continuous cardiovascular insights.

  • Dashboard monitoring
  • Alert-based workflows
  • Trend analysis for intervention

The Complete Process

Five clear steps from onboarding to clinical action

One Time Initialization

The foundation of accurate, personalized estimation begins with a comprehensive personalization session with a quick but robust initialization session.

Wearable Signals

Clinically adopted smartwatches (this filters the non-fda cleared watches and tells FDA we dont aprove ALL DEVICES) , and only Apple and Samsung of the world

Other securely-accessed patient data

Echocardiographic data for structural and functional assessment

Blood Pressure Cuff

Noninvasive blood pressure measurement in-office or at-home

Personalization

Patient-specific AI model generated for hemodynamics estimation

One Time Initialization

The foundation of accurate, personalized estimation begins with a comprehensive personalization session with a quick but robust initialization session.

Change to on-demand daily spot check

Flexible monitoring frequency based on clinical needs

Repeated monitoring without invasive procedures

Continuous cardiovascular visibility over time

CPSE powered Hemodynamic monitoring

Advanced algorithms transform wearable signals into clinical insights

Signal Inputs

  • Photoplethysmography (PPG)
  • Electrocardiogram (ECG)
  • Blood Pressure (BP)
  • Patient-Specific Calibration Data

Hemodynamic Outputs

Physics-based modeling combined with machine learning creates a patient-specific digital twin that estimates hemodynamic parameters with catheter-level accuracy, all from non-invasive wearable signals.

Clinical Review & Action

Clinicians access comprehensive dashboards to review trends, monitor patients, and take action earlier.

Clearer Monitoring

Clinically adopted smartwatches (this filters the non-fda cleared watches and tells FDA we dont aprove ALL DEVICES) , and only Apple and Samsung of the world

Faster Follow-Up

Echocardiographic data for structural and functional assessment

Continuous Insights

Longitudinal trend analysis for better care decisions

Frequently Asked Questions

A revolutionary approach that doesn’t sacrifice on accuracy and complements care where invasive devices are not accessible

A revolutionary approach that doesn’t sacrifice on accuracy and complements care where invasive devices are not accessible

A revolutionary approach that doesn’t sacrifice on accuracy and complements care where invasive devices are not accessible

A revolutionary approach that doesn’t sacrifice on accuracy and complements care where invasive devices are not accessible

Connect with Coredio Team!

Join the clinicians who are exploring the future of cardiovascular monitoring

FDA

Desclaimer: CoreDio CPSE™ has received FDA Breakthrough Device Designation. The device is not yet cleared by the FDA for commercial use. The Indications for Use are subject to FDA review during the 510(k) process.